Award-winning documentary hosted by actor Dennis Quaid invites Circularity to talk about D’OXYVA

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on reddit
Share on tumblr
Share on telegram
Share on whatsapp

Recently, VIEWPOINT Project (https://viewpointproject.com/) invited Circularity Healthcare to participate with its D’OXYVA product line in the critically-acclaimed, award-winning and stunning documentary series hosted by actor Dennis Quaid. Everyone at Circularity is delighted and honored to participate in this amazing opportunity.

In this short-form documentary, Circularity will showcase its world-class medical experts who are regularly called upon to testify in front of the U.S. Food and Drug Administration (FDA). This episode of the documentary focuses on the vast, Nobel-winning science Circularity’s scientific team is unlocking and harnessing to deliver unprecedented clinical outcomes in diabetic wound care and radical changes in the standard of care for cardiovascular patients. Circularity’s breakthrough pivotal clinical trial with its FDA-approved D’OXYVA noninvasive transdermal pharmaceutical product line for diabetics with chronic wounds is involving 18 of the top 20 U.S. universities, while shining light on the engineering marvel behind its technology.

The VIEWPOINT short-form documentary series will be distributed to Public Television stations in all 50 states. The overall project will include the production of an educational segment running for 3-5 minutes as a standalone short-form documentary for distribution to PBS nationwide with an estimated reach of well-over 100 million households within a year.

The segment will be broadcast once primetime in over 84 million homes via large news networks. The educational commercial segment will also air 400 times in many of the top 100 Designated Marketing Areas during peak and primetime on networks such as CNBC, CNN, CNN Headline News, Discovery Life, Fox Business Network, The Learning Channel, Discovery Channel, or equivalent networks (a media schedule will be set in advance to guarantee these spots, and post airing affidavits (proof of airing) will be provided following the airings.

VIEWPOINT will digitize the segments into digital files for streaming on the company’s website and will be delivered in a format for streaming on social media sites. VIEWPOINT will design and generate an email campaign to the company’s narrowcasted audience sending up to one million video emails from our email database that can be expanded upon request by Circularity.

physician-recommended, easy to use daily

Why Use D'OXYVA?

Experts say D’OXYVA® can help patients find relief. Overwhelming medical data shows people with preexisting conditions, including diabetes may experience serious complications with COVID-19. D’OXYVA significantly helps people and their pets by gently and quickly spraying a patented and patent-pending ultra-purified, supersaturated solution on the skin surface to achieve major health benefits for well over 90% of users. Experts call D’OXYVA a game-changer biotech. “Studies with D’OXYVA have shown unmatched results in noninvasive wound care. Anyone with an underlying condition should know this option is available.” -Dr. Michael McGlamry

Reduce unwanted doctor visits, recommended
and ranked top by experts!

Leave a Reply

Your email address will not be published. Required fields are marked *